CHEYENNE – Cheyenne Regional Medical Center has announced a new treatment option for patients with complex Peripheral Artery Disease (PAD).

Please provide your email address to receive an email when new articles are posted on . Endovascular therapy confers similar outcomes and lower complication rates vs. bypass surgery for ...

June 11, 2009 (Denver, Colorado) — The preoperative functional status of patients with peripheral arterial disease (PAD) who are candidates for lower-extremity bypass surgery is a highly significant ...

PQ Bypass has gathered $60 million in equity financing to move forward with its minimally invasive technology for treating long blockages in leg arteries caused by peripheral artery disease. The round ...

In a small randomized controlled study, endoluminal bypass with heparin-bonded covered stents demonstrated several advantages over conventional femoropopliteal surgery in patients with long occlusive ...

SUNNYVALE, Calif.--(BUSINESS WIRE)--Results from the DETOUR I Trial evaluating the PQ Bypass DETOUR System for percutaneous bypass showed promising 12-month durability for patients with extremely long ...

Compared with surgery, PAD patients treated with bare-metal, covered, or drug-eluting stents have similar efficacy and safety outcomes at 2 years, the REVIVE pooled analysis shows. Combining ...

Patients with femoropopliteal disease who receive stenting are more likely to have patent vessels and less likely to need reintervention after 2 years than their counterparts who undergo surgical ...